HOME > Investors > Press Releases
2012-03-30
ViroMed receives approval for Phase III of VM501 by China FDA
2011-11-16
ViroMed receives approval for Phase II trial in the US for Diabetic Peripheral Neuropathy
2011-10-14
ViroMed Takes One Step Closer to Finding a Cure for Diabetic Neuropathy through US Clinical Trial I/II
2011-10-13
ViroMed’s DNA Medicine(VM202) Receives Phase II Approval for PAD in China
2011-03-18
ViroMed Announces Final Patient Enrollment for US VM202-DPN Clinical Trial
11 12 13 14 15 16 17 18 19